-+ 0.00%
-+ 0.00%
-+ 0.00%

Luye Pharma Gets FDA Clearance for LY03021 Depression Drug Trials

PUBT·11/17/2026 04:03:08
Listen to the news
Luye Pharma Gets FDA Clearance for LY03021 Depression Drug Trials
  • Luye Pharma received U.S. FDA clearance to begin clinical trials of LY03021 for major depressive disorder.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Luye Pharma Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261117-12415201), on November 17, 2026, and is solely responsible for the information contained therein.